AIMT

Aimmune Therapeutics
AIMT

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

AIMT was delisted on the 12th of October, 2020.

Back to rankings

58 hedge funds and large institutions have $551M invested in Aimmune Therapeutics in 2015 Q3 according to their latest regulatory filings, with 58 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
58
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$154M
2
+$104M
3
+$71.4M
4
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$31.4M
5
PHS
PFM Health Sciences
California
+$25.2M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$154M
2
$104M
3
$71.4M
4
$31.4M
5
$25.2M
6
$20.1M
7
$20M
8
$18.1M
9
$15.3M
10
$14.3M
11
$11.2M
12
$8.24M
13
$6.73M
14
$6.33M
15
$5.08M
16
$5.06M
17
$3.75M
18
$3.08M
19
$2.63M
20
$2.08M
21
$1.94M
22
$1.73M
23
$1.69M
24
$1.67M
25
$1.63M
1
2 3